Recent in vitro data support the idea that in addition to being a boundary lubricant and possessing anti-adhesive properties, rhPRG4 may compete with HA for CD44 binding, which may suppress downstream signalling, contributing to the proliferation of osteoarthritis- and rheumatoid arthritis-derived synoviocytes [9,10]. Here, CD44 is linked to osteoarthritis.